T. Rowe Price Investment Management, Inc. Ionis Pharmaceuticals Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 14,169,199 shares of IONS stock, worth $467 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
14,169,199
Previous 14,168,116
0.01%
Holding current value
$467 Million
Previous $568 Million
12.72%
% of portfolio
0.31%
Previous 0.34%
Shares
10 transactions
Others Institutions Holding IONS
# of Institutions
412Shares Held
140MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$543 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$378 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$340 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$286 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$259 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.68B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...